Literature DB >> 8681599

Prospective, controlled study of the outcome of human immunodeficiency virus-1 antibody-positive children admitted to an intensive care unit.

P M Jeena1, H M Coovadia, S Bhagwanjee.   

Abstract

OBJECTIVE: Intensive care resources are both scarce and costly in South Africa. We set out to ascertain whether human immunodeficiency virus (HIV) status affects the spectrum of disease and the prognosis in children treated in pediatric intensive care units (ICUs).
DESIGN: A prospective, case-controlled study.
SETTING: The pediatric ICU at Kind Edward VIII Hospital, Durban, South Africa. PATIENTS: HIV-positive cases were classified as "acquired immunodeficiency syndrome," "symptomatic HIV," and "HIV-unrelated diseases." Controls were matched for age, race, gender, severity of disease, and admitting diagnosis.
MEASUREMENTS AND MAIN RESULTS: THe clinician was blinded to the serostatus of patients. Informed consent and Ethics Committee approval were obtained for HIV testing and the study. Outcome measures were the duration of intermittent positive-pressure ventilation and ICU stay, maximum ventilatory requirements, infectious complications, and mortality. There were 11 cases of acquired immune deficiency (AIDS), 24 cases of symptomatic HIV, and 13 cases of HIV-unrelated diseases. Mortality rates for the three groups were as follows: 100% in patients with AIDS compared with 55% in their controls (p<.01); 38% in patients with symptomatic HIV and 46% in controls. Cytomegalovirus and Pneumocystis carinii infections were significantly increased (p<.01, p<.002, respectively) in patients with AIDS as compared with controls. Outcome measures were similar in those patients with symptomatic HIV and those patients with HIV-unrelated diseases, as compared with their respective controls.
CONCLUSIONS: Outcome in children with AIDS admitted to the pediatric ICU was significantly worse than the outcome in HIV-uninfected children. However, the number of AIDS patients studied was small. HIV antibody-positive children without AIDS do as well as uninfected controls. Ethics committees in resource-constrained countries may be assisted by such data when making difficult decisions on the admissions of HIV-infected patients to pediatric ICU facilities.

Entities:  

Mesh:

Year:  1996        PMID: 8681599     DOI: 10.1097/00003246-199606000-00015

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  The effect of stage of HIV disease as determined by CD4 count on clinical outcomes of surgical sepsis in South Africa.

Authors:  S Green; V Y Kong; G L Laing; J L Bruce; J Odendaal; B Sartorius; D L Clarke
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

2.  Challenges in the provision of ICU services to HIV infected children in resource poor settings: a South African case study.

Authors:  P M Jeena; L M McNally; M Stobie; H M Coovadia; M A Adhikari; A J Petros
Journal:  J Med Ethics       Date:  2005-04       Impact factor: 2.903

3.  Short-term mortality and implementation of antiretroviral treatment for critically ill HIV-infected children in a developing country.

Authors:  C Cowburn; M Hatherill; B Eley; J Nuttall; G Hussey; L Reynolds; Z Waggie; L Vivian; A Argent
Journal:  Arch Dis Child       Date:  2006-05-02       Impact factor: 3.791

4.  Children with human immunodeficiency virus admitted to a paediatric intensive care unit in the United Kingdom over a 10-year period.

Authors:  Sian Cooper; Hermione Lyall; Sam Walters; Gareth Tudor-Williams; Parviz Habibi; Claudine de Munter; Joseph Britto; Simon Nadel
Journal:  Intensive Care Med       Date:  2003-11-13       Impact factor: 17.440

5.  Managing HIV in the PICU--the experience at the Red Cross War Memorial Children's Hospital in Cape Town.

Authors:  A C Argent
Journal:  Indian J Pediatr       Date:  2008-08-31       Impact factor: 1.967

6.  Mortality following snake bite envenomation by Bitis arietans in an HIV positive child: A case report.

Authors:  Gregory B Firth; Matthew Street; Yammesh Ramguthy; Linda Doedens
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.